MMSI Quote, Financials, Valuation and Earnings

Enovis Corp. has a net margin of 7.22% compared to Merit Medical Systems, Inc.'s net margin of -104%. Merit Medical Systems, Inc.'s return on equity of 8.28% beat Enovis Corp.'s return on equity of -52.07%.

Merit Medical Systems, Inc. has a consensus price target of $103.00, signalling upside risk potential of 22.2%. On the other hand Enovis Corp. has an analysts' consensus of $48.11 which suggests that it could grow by 64.31%. Given that Enovis Corp. has higher upside potential than Merit Medical Systems, Inc., analysts believe Enovis Corp. is more attractive than Merit Medical Systems, Inc..

Merit Medical Systems, Inc. has a beta of 0.615, which suggesting that the stock is 38.504% less volatile than S&P 500. In comparison Enovis Corp. has a beta of 1.284, suggesting its more volatile than the S&P 500 by 28.371%.

Merit Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Enovis Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems, Inc. pays -- of its earnings as a dividend. Enovis Corp. pays out -- of its earnings as a dividend.

Merit Medical Systems, Inc. quarterly revenues are $384.3M, which are smaller than Enovis Corp. quarterly revenues of $548.9M. Merit Medical Systems, Inc.'s net income of $27.8M is higher than Enovis Corp.'s net income of -$570.9M. Notably, Merit Medical Systems, Inc.'s price-to-earnings ratio is 43.14x while Enovis Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems, Inc. is 3.46x versus 0.74x for Enovis Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Integra LifeSciences Holdings Corp. has a net margin of 7.22% compared to Merit Medical Systems, Inc.'s net margin of -1.34%. Merit Medical Systems, Inc.'s return on equity of 8.28% beat Integra LifeSciences Holdings Corp.'s return on equity of -37.15%.

Merit Medical Systems, Inc. has a consensus price target of $103.00, signalling upside risk potential of 22.2%. On the other hand Integra LifeSciences Holdings Corp. has an analysts' consensus of $15.50 which suggests that it could grow by 14.9%. Given that Merit Medical Systems, Inc. has higher upside potential than Integra LifeSciences Holdings Corp., analysts believe Merit Medical Systems, Inc. is more attractive than Integra LifeSciences Holdings Corp..

Merit Medical Systems, Inc. has a beta of 0.615, which suggesting that the stock is 38.504% less volatile than S&P 500. In comparison Integra LifeSciences Holdings Corp. has a beta of 1.064, suggesting its more volatile than the S&P 500 by 6.408%.

Merit Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Integra LifeSciences Holdings Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems, Inc. pays -- of its earnings as a dividend. Integra LifeSciences Holdings Corp. pays out -- of its earnings as a dividend.

Merit Medical Systems, Inc. quarterly revenues are $384.3M, which are smaller than Integra LifeSciences Holdings Corp. quarterly revenues of $402.1M. Merit Medical Systems, Inc.'s net income of $27.8M is higher than Integra LifeSciences Holdings Corp.'s net income of -$5.4M. Notably, Merit Medical Systems, Inc.'s price-to-earnings ratio is 43.14x while Integra LifeSciences Holdings Corp.'s PE ratio is 70.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems, Inc. is 3.46x versus 0.63x for Integra LifeSciences Holdings Corp.. Usually stocks with elevated PS ratios are considered overvalued.

ICU Medical, Inc. has a net margin of 7.22% compared to Merit Medical Systems, Inc.'s net margin of -0.63%. Merit Medical Systems, Inc.'s return on equity of 8.28% beat ICU Medical, Inc.'s return on equity of -0.36%.

Merit Medical Systems, Inc. has a consensus price target of $103.00, signalling upside risk potential of 22.2%. On the other hand ICU Medical, Inc. has an analysts' consensus of $178.33 which suggests that it could grow by 25.54%. Given that ICU Medical, Inc. has higher upside potential than Merit Medical Systems, Inc., analysts believe ICU Medical, Inc. is more attractive than Merit Medical Systems, Inc..

Merit Medical Systems, Inc. has a beta of 0.615, which suggesting that the stock is 38.504% less volatile than S&P 500. In comparison ICU Medical, Inc. has a beta of 0.823, suggesting its less volatile than the S&P 500 by 17.719%.

Merit Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ICU Medical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems, Inc. pays -- of its earnings as a dividend. ICU Medical, Inc. pays out -- of its earnings as a dividend.

Merit Medical Systems, Inc. quarterly revenues are $384.3M, which are smaller than ICU Medical, Inc. quarterly revenues of $537.7M. Merit Medical Systems, Inc.'s net income of $27.8M is higher than ICU Medical, Inc.'s net income of -$3.4M. Notably, Merit Medical Systems, Inc.'s price-to-earnings ratio is 43.14x while ICU Medical, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems, Inc. is 3.46x versus 1.53x for ICU Medical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Masimo Corp. has a net margin of 7.22% compared to Merit Medical Systems, Inc.'s net margin of 14.46%. Merit Medical Systems, Inc.'s return on equity of 8.28% beat Masimo Corp.'s return on equity of -19.18%.

Merit Medical Systems, Inc. has a consensus price target of $103.00, signalling upside risk potential of 22.2%. On the other hand Masimo Corp. has an analysts' consensus of $183.13 which suggests that it could grow by 32.61%. Given that Masimo Corp. has higher upside potential than Merit Medical Systems, Inc., analysts believe Masimo Corp. is more attractive than Merit Medical Systems, Inc..

Merit Medical Systems, Inc. has a beta of 0.615, which suggesting that the stock is 38.504% less volatile than S&P 500. In comparison Masimo Corp. has a beta of 1.262, suggesting its more volatile than the S&P 500 by 26.208%.

Merit Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Masimo Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems, Inc. pays -- of its earnings as a dividend. Masimo Corp. pays out -- of its earnings as a dividend.

Merit Medical Systems, Inc. quarterly revenues are $384.3M, which are larger than Masimo Corp. quarterly revenues of $371.5M. Merit Medical Systems, Inc.'s net income of $27.8M is lower than Masimo Corp.'s net income of $53.7M. Notably, Merit Medical Systems, Inc.'s price-to-earnings ratio is 43.14x while Masimo Corp.'s PE ratio is 116.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems, Inc. is 3.46x versus 4.36x for Masimo Corp.. Usually stocks with elevated PS ratios are considered overvalued.